Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

082022-04

List of directors and their roles and functions
082022-04

Resignation of Director, Company Secretary and Chief Financial Officer; Change in the Composition of Board Committees; Appointment of Joint Company Secretaries; Change in Authorized Representative; Appointment of Person-in-charge of Finance; and Waiver from Strict Compliance with Rules 3.28 and 8.17 of the Listing Rules
012022-04

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
312022-03

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
212022-03

NOTICE OF BOARD MEETING The board of directors (the “Board”) of Charmacy Pharmaceutical Co., Ltd.
022022-03

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
282022-02

Profit Warning
252022-02

CHANGE OF PROCESS AGENT
152022-02

INSIDE INFORMATION-PROPOSED PARTICIPATION IN THE H SHARE FULL CIRCULATION PROGRAMME BY THE COMPANY
072022-02

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
062022-01

VOLUNTARY ANNOUNCEMENT TRANSFER OF DOMESTIC SHARES BY DOMESTIC SHAREHOLDERS
042022-01

ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE, RULE 13.09(2)(a) OF THE LISTING RULES AND INSIDE INFORMATION PROVISIONS UNDER PART XIVA OF THE SFO AND END OF OFFER PERIOD

2 3 4 5 6

The Enterprise OA